JPRN-jRCTs031180092已完成未知
Effect of anti-immunoglobulin E therapy on chronic prurigo and cholinergic urticaria - Effect of anti-immunoglobulin E therapy on chronic prurigo and cholinergic urticaria
Yokozeki Hiroo0 个研究点目标入组 10 人开始时间: 2019年1月22日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
This study showed that omalizumab might be effective and safe for the treatment of skin diseases which resemble to chronic spontaneous urticaria such as chronic prurigo and cholinergic urticaria.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •patients who are resistant to the treatments such as topical administration of steroid and orally administration of anti-histamine drugs
- •patients at age 20 or over
- •out patients
排除标准
- •patients orally administrated immune suppressants or high-dose steroid within three months.
- •patients suffering from severe visceral diseases, autoimmune diseases, blood dosorders, and mental disorders
- •patients who is pregnant or breast-feed
- •patients judged inadequate to this study
研究者
相似试验
进行中（未招募）
不适用
Combination Therapy of Omalizumab and Allergen Immunotherapy for Moderate to Severe AsthmaAllergic AsthmaNCT06771934Qianfoshan Hospital60
Unknown
2 期
Omalizumab in Non-atopic AsthmaBronchial AsthmaNCT01113437King's College London40
尚未招募
不适用
Trial of anti IgE in RA.Rheumatoid arthritisNL-OMON28491eiden University Medical Center80
尚未招募
不适用
Trial of anti IgE in RA.Rheumatoid arthritis, anti-IgE, IgE-ACPA, CCPNL-OMON25810eiden University Medical Center10
Unknown
不适用
Efficacy and Safety of Omalizumab in Patients With Severe Acute UrticariaUrticariaNCT02191072National Taiwan University Hospital20